Azitra, Inc. (AZTR): Aggregate Business Value

Azitra, Inc. (AZTR) relies on external contractors for research and product release, fully outsourcing its production. The firm's activities in treating rare skin pathologies remain independent of economic fluctuations, as success is based on test results. The current enterprise value is -1.99, which is detailed in the market trend.

Enterprise Value (EV) determines the actual cost for a strategic buyer to fully acquire an asset by summing market capitalization and net debt. By analyzing the evolution of business value, an investor assesses the attractiveness of Azitra, Inc., whose value is currently driven by the potential for automating bioreactors for the synthesis of skin proteins without human intervention, thereby minimizing operational contamination risks.